18 results on '"Kesselheim, Aaron S."'
Search Results
2. Regulating Off-Label Promotion - A Critical Test.
3. The 21st Century Cures Act -- Will It Take Us Back in Time?
4. User Fees and Beyond — The FDA Safety and Innovation Act of 2012.
5. Pharmaceutical Marketing and the New Social Media.
6. A New Way to Contain Unaffordable Medication Costs - Exercising the Government's Existing Rights.
7. The Watchman Saga -- Closure at Last?
8. The FDA Breakthrough-Drug Designation - Four Years of Experience.
9. Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI.
10. The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health.
11. Forbidden and Permitted Statements about Medications -- Loosening the Rules.
12. Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer.
13. FDA Regulation of Mobile Health Technologies.
14. New FDA Breakthrough-Drug Category -- Implications for Patients.
15. Regulation of Medical Devices in the United States and European Union.
16. Using a Drug-Safety Tool to Prevent Competition.
17. Revisiting FDA Approval of Aducanumab.
18. Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.